Interleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle Hypertrophy

Cell Metabolism

Volumn 7, Issue 1, 2008, Pages 33-44

  Serrano, Antonio L ^a   Baeza Raja, Bernat ^a   Perdiguero, Eusebio ^a   Jardí, Mercè ^a   Muñoz Cánoves, Pura ^a  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

HUMDISEASE; SIGNALING

Indexed keywords

CYCLIN D1; INTERLEUKIN 6; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; GENE LOSS; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE GROWTH; MUSCLE HYPERTROPHY; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN FUNCTION; SKELETAL MUSCLE SATELLITE CELL; TRANSCRIPTION INITIATION;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN D1; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MICE; MICE, KNOCKOUT; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOBLASTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SATELLITE CELLS, SKELETAL MUSCLE; STAT3 TRANSCRIPTION FACTOR;

EID: 37449022587     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2007.11.011     Document Type: Article

References (54)

1. Adams G.R. Satellite cell proliferation and skeletal muscle hypertrophy. Appl. Physiol. Nutr. Metab. 31 (2006) 782-790
2. Adams G.R., Caiozzo V.J., Haddad F., and Baldwin K.M. Cellular and molecular responses to increased skeletal muscle loading after irradiation. Am. J. Physiol. Cell Physiol. 283 (2002) C1182-C1195
3. Baeza-Raja B., and Munoz-Canoves P. p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6. Mol. Biol. Cell 15 (2004) 2013-2026
4. Banzet S., Koulmann N., Sanchez H., Serrurier B., Peinnequin A., Alonso A., and Bigard X. Contraction-induced interleukin-6 transcription in rat slow-type muscle is partly dependent on calcineurin activation. J. Cell. Physiol. 210 (2007) 596-601
5. Bartoccioni E., Michaelis D., and Hohlfeld R. Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol. Lett. 42 (1994) 135-138
6. Birchmeier C., and Brohmann H. Genes that control the development of migrating muscle precursor cells. Curr. Opin. Cell Biol. 12 (2000) 725-730
7. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., Zlotchenko E., Scrimgeour A., Lawrence J.C., Glass D.J., and Yancopoulos G.D. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3 (2001) 1014-1019
8. Bonavaud S., Charrierre-Bertrand C., Rey C., Leibovitch M., Pedersen N., Frisdal E., Planus E., Blasi F., Gherardi R., and Barlovatz-Meimon G. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion. J. Cell Sci. 110 (1997) 1083-1089
9. Carson J.A., Nettleton D., and Reecy J.M. Differential gene expression in the rat soleus muscle during early work overload-induced hypertrophy. FASEB J. 16 (2002) 207-209
10. Crescenzi M., Fleming T.P., Lassar A.B., Weintraub H., and Aaronson S.A. MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. USA 87 (1990) 8442-8446
11. Dani C., Chambers I., Johnstone S., Robertson M., Ebrahimi B., Saito M., Taga T., Li M., Burdon T., Nichols J., and Smith A. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. Dev. Biol. 203 (1998) 149-162
12. Darr K.C., and Schultz E. Hindlimb suspension suppresses muscle growth and satellite cell proliferation. J. Appl. Physiol. 67 (1989) 1827-1834
13. De Rossi M., Bernasconi P., Baggi F., de Waal Malefyt R., and Mantegazza R. Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. Int. Immunol. 12 (2000) 1329-1335
14. Dhawan J., and Rando T.A. Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol. 15 (2005) 666-673
15. Endo T., and Nadal-Ginard B. Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype. Mol. Cell. Biol. 6 (1986) 1412-1421
16. Ernst M., and Jenkins B.J. Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet. 20 (2004) 23-32
17. Forcales S.V., and Puri P.L. Signaling to the chromatin during skeletal myogenesis: novel targets for pharmacological modulation of gene expression. Semin. Cell Dev. Biol. 16 (2005) 596-611
18. Glass D.J. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat. Cell Biol. 5 (2003) 87-90
19. Glass D.J. Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 37 (2005) 1974-1984
20. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin Jr. A.S. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19 (1999) 5785-5799
21. Haddad F., Zaldivar F., Cooper D.M., and Adams G.R. IL-6-induced skeletal muscle atrophy. J. Appl. Physiol. 98 (2005) 911-917
22. Halevy O., Novitch B.G., Spicer D.B., Skapek S.X., Rhee J., Hannon G.J., Beach D., and Lassar A.B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267 (1995) 1018-1021
23. Hiscock N., Chan M.H., Bisucci T., Darby I.A., and Febbraio M.A. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J. 18 (2004) 992-994
24. Horsley V., Jansen K.M., Mills S.T., and Pavlath G.K. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113 (2003) 483-494
25. Jonsdottir I.H., Schjerling P., Ostrowski K., Asp S., Richter E.A., and Pedersen B.K. Muscle contractions induce interleukin-6 mRNA production in rat skeletal muscles. J. Physiol. 528 (2000) 157-163
26. Kami K., and Senba E. In vivo activation of STAT3 signaling in satellite cells and myofibers in regenerating rat skeletal muscles. J. Histochem. Cytochem. 50 (2002) 1579-1589
27. Kamimura D., Ishihara K., and Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149 (2003) 1-38
28. Kataoka Y., Matsumura I., Ezoe S., Nakata S., Takigawa E., Sato Y., Kawasaki A., Yokota T., Nakajima K., Felsani A., and Kanakura Y. Reciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblasts. J. Biol. Chem. 278 (2003) 44178-44187
29. Keller C., Steensberg A., Pilegaard H., Osada T., Saltin B., Pedersen B.K., and Neufer P.D. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J. 15 (2001) 2748-2750
30. Kishimoto T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu. Rev. Immunol. 23 (2005) 1-21
31. Kitzmann M., and Fernandez A. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell. Mol. Life Sci. 58 (2001) 571-579
32. Kiuchi N., Nakajima K., Ichiba M., Fukada T., Narimatsu M., Mizuno K., Hibi M., and Hirano T. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J. Exp. Med. 189 (1999) 63-73
33. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., and Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368 (1994) 339-342
34. Li Z., Wang C., Prendergast G., and Pestell R.G. Cyclin D1 functions in cell migration. Cell Cycle 5 (2006) 2440-2442
35. Masuda M., Suzui M., Yasumatu R., Nakashima T., Kuratomi Y., Azuma K., Tomita K., Komiyama S., and Weinstein I.B. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res. 62 (2002) 3351-3355
36. McLemore M.L., Grewal S., Liu F., Archambault A., Poursine-Laurent J., Haug J., and Link D.C. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14 (2001) 193-204
37. Mourkioti F., and Rosenthal N. IGF-1, inflammation and stem cells: interactions during muscle regeneration. Trends Immunol. 26 (2005) 535-542
38. O'Connor R.S., Pavlath G.K., McCarthy J.J., and Esser K.A. Last Word on Point:Counterpoint: Satellite cell addition is/is not obligatory for skeletal muscle hypertrophy. J. Appl. Physiol. 103 (2007) 1107
39. Pedersen B.K., and Fischer C.P. Beneficial health effects of exercise--the role of IL-6 as a myokine. Trends Pharmacol. Sci. 28 (2007) 152-156
40. Penkowa M., Keller C., Keller P., Jauffred S., and Pedersen B.K. Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J. 17 (2003) 2166-2168
41. Perdiguero E., Ruiz-Bonilla V., Gresh L., Hui L., Ballestar E., Sousa-Victor P., Baeza-Raja B., Jardi M., Bosch-Comas A., Esteller M., et al. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J. 26 (2007) 1245-1256
42. Rao S.S., Chu C., and Kohtz D.S. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14 (1994) 5259-5267
43. Rose-John S. Interleukin-6 biology is coordinated by membrane bound and soluble receptors. Acta Biochim. Pol. 50 (2003) 603-611
44. Rosenblatt J.D., and Parry D.J. Gamma irradiation prevents compensatory hypertrophy of overloaded mouse extensor digitorum longus muscle. J. Appl. Physiol. 73 (1992) 2538-2543
45. Rosenblatt J.D., and Parry D.J. Adaptation of rat extensor digitorum longus muscle to gamma irradiation and overload. Pflugers Arch. 423 (1993) 255-264
46. Rosenblatt J.D., Yong D., and Parry D.J. Satellite cell activity is required for hypertrophy of overloaded adult rat muscle. Muscle Nerve 17 (1994) 608-613
47. Schiaffino S., and Serrano A. Calcineurin signaling and neural control of skeletal muscle fiber type and size. Trends Pharmacol. Sci. 23 (2002) 569-575
48. Sorrentino V., Pepperkok R., Davis R.L., Ansorge W., and Philipson L. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature 345 (1990) 813-815
49. Tisdale M.J. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J. Support. Oncol. 3 (2005) 209-217
50. Turkson J., Ryan D., Kim J.S., Zhang Y., Chen Z., Haura E., Laudano A., Sebti S., Hamilton A.D., and Jove R. Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J. Biol. Chem. 276 (2001) 45443-45455
51. Turner D.C., Lawton J., Dollenmeier P., Ehrismann R., and Chiquet M. Guidance of myogenic cell migration by oriented deposits of fibronectin. Dev. Biol. 95 (1983) 497-504
52. Viswanathan S., Benatar T., Rose-John S., Lauffenburger D.A., and Zandstra P.W. Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6. Stem Cells 20 (2002) 119-138
53. Wei Q., and Paterson B.M. Regulation of MyoD function in the dividing myoblast. FEBS Lett. 490 (2001) 171-178
54. Wells J.M., and Strickland S. Regulated localization confers multiple functions on the protease urokinase plasminogen activator. J. Cell. Physiol. 171 (1997) 217-225